Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs

BACKGROUND: This laboratory study compared the efficacy of Bravecto™ (fluralaner), formulated as a chewable tablet, with the efficacy of Advocate® (imidacloprid/moxidectin), formulated for topical administration, against naturally acquired generalized demodicosis in dogs. METHODS: Sixteen dogs, all...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Parasit Vectors
Autors principals: Fourie, Josephus J, Liebenberg, Julian E, Horak, Ivan G, Taenzler, Janina, Heckeroth, Anja R, Frénais, Regis
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394402/
https://ncbi.nlm.nih.gov/pubmed/25881320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-015-0775-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars